Innovative Health Sciences to Showcase its State of the Art Insignistm Syringe Infusion System at Medica 2021

Innovative Health Sciences, LLC ("IHS" or the "Company") will be presenting its breakthrough versatile and low cost non-electric infusion system at Medica, a world-renowned trade fair for medical devices and medical technologies, November 15 ? November 18. IHS Director of European Sales, Nektarios Manatos will be showcasing the Insignistm Syringe Infusion System in Hall 6, booth B80 alongside Assut Europe SpA.

The Insignistm Syringe Infusion System is the first combination of intravenous and subcutaneous non-electric infusion pump created for use with a selectable rate flow controller, the IV Controller and the OneSetttm. The transformative Insignistm System for intravenous administration answers the world-wide need for a portable, non-electric, versatile, cost-effective, and intuitive infusion pump to accurately deliver medications from KVO up to 250ml/hr with a direct reading selectable rate flow controller.

"Medica is a great opportunity for IHS to introduce the Insignistm family of products to the industry ? it's a place where cutting edge medical technologies and groundbreaking innovation are center stage," says Andrew Sealfon, Chairman, Founder, and Chief Technology Officer. "It's the perfect setting for IHS to showcase our products." IHS has worked tirelessly to improve infusion technologies and is excited to bring this new medical paradigm to the infusion industry.

IHS received CE Certification for the Insignistm Syringe Infusion System earlier this year, which enables sales in the European Union. The Insignis ?26Gtm Subcutaneous Needle Sets are FDA cleared in the U.S. and IHS expects to receive full regulatory clearance for the entire Insignistm system in the next few weeks.

About Innovative Health Sciences

New York-based Innovative Health Sciences, LLC provides innovative solutions to the infusion healthcare market. IHS' approach is patient-centric and future-oriented; our goal is to provide the highest quality of life by empowering the patient to take control of their infusion. For more information on the Company and the products, be sure to check out the new website, www.innohealthsci.com.

Forward-Looking Statements

The statements contained herein are not guaranteed of future performance and undue reliance should not be placed on them. Such Forward-Looking Statements necessarily involve known and unknown risks and uncertainties, which may cause actual performance and financial results in future periods to differ materially from any projections of future performance or results expressed or implied. These statements are based on management's beliefs and theory. The Company undertakes no obligation to update Forward-Looking Statements if circumstances or management's estimates or opinions should change, except as required by applicable securities laws.